Host: House of Data - Imperiali & Federchimica Assobiotec
Many of the successful paths in scientific research and clinical trials begin with patient data and personal information. Innovations in drugs, treatments and products take data on a necessarily dynamic and extended journey. Thus, the need of companies to move easily in ever new contexts is accompanied by the need to collect, manage and protect data and information in an ever more secure way.
What are the ways in which companies can do this while fully respecting privacy and fully exploiting the opportunities offered by scientific research?
The meeting aims to bring out the opportunities and risks of the increasingly close relationship between data and health, in a new context full of uncertainties, but also of great opportunities to positively feed the activities of companies.